Crestline Management LP Reduces Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Crestline Management LP lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 61.9% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 556 shares of the healthcare conglomerate's stock after selling 902 shares during the period. Crestline Management LP's holdings in UnitedHealth Group were worth $281,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Western Pacific Wealth Management LP boosted its stake in shares of UnitedHealth Group by 2.2% during the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock valued at $456,000 after purchasing an additional 19 shares in the last quarter. MCF Advisors LLC lifted its stake in shares of UnitedHealth Group by 0.8% during the 4th quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate's stock worth $1,304,000 after purchasing an additional 20 shares during the last quarter. Axiom Financial Strategies LLC raised its holdings in UnitedHealth Group by 3.6% in the fourth quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock worth $291,000 after purchasing an additional 20 shares in the last quarter. Richwood Investment Advisors LLC grew its position in shares of UnitedHealth Group by 0.4% in the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after buying an additional 20 shares during the last quarter. Finally, Prentice Wealth Management LLC lifted its position in UnitedHealth Group by 0.8% during the fourth quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate's stock valued at $1,278,000 after acquiring an additional 21 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Down 1.0%

Shares of UNH stock traded down $3.03 on Wednesday, hitting $308.35. 37,544,964 shares of the stock traded hands, compared to its average volume of 5,099,212. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm's 50-day moving average price is $482.53 and its two-hundred day moving average price is $519.28. UnitedHealth Group Incorporated has a twelve month low of $307.19 and a twelve month high of $630.73. The stock has a market capitalization of $279.72 billion, a PE ratio of 19.89, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the firm earned $6.91 EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 2.72%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is 35.18%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent analyst reports. Erste Group Bank cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. JPMorgan Chase & Co. lowered their target price on shares of UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. HSBC reissued a "hold" rating and set a $490.00 price objective on shares of UnitedHealth Group in a report on Tuesday, April 22nd. Wells Fargo & Company lowered their price target on UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a research report on Wednesday. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a report on Wednesday. Six equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and an average price target of $523.52.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.